Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Immediate Lymphatic Repair at Lymph Node Surgery for Melanoma Patients

Official title: Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study

Run by M.D. Anderson Cancer Center · NCT06887205 · Data updated 2026-11-12

This study tests whether doing a lymphovenous bypass during lymph node removal for melanoma can help prevent lymphedema and improve recovery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorM.D. Anderson Cancer Center
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedJune 10, 2026
Main results expectedSeptember 1, 2028
Study endsSeptember 1, 2028
Registry record updatedJune 18, 2026
Trial IDNCT06887205 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with melanoma undergoing axillary or inguinal lymph node dissection who consent to participate and can complete assessments.

Probably not a fit

Patients with BMI >50, current pregnancy, recent use of anticoagulants, or other contraindications may not benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional pilot study looks at performing lymphovenous bypass at the time of axillary or inguinal lymph node dissection in melanoma patients. It will measure how often lymphedema occurs within the first year after surgery, plus wound complications in 30 days, drain removal timing, and patient-reported quality of life. The study tracks LE prevalence at 3, 6, and 12 months, and estimates the time to first LE and cumulative incidence. LYMQOL is used to assess survivorship and lifestyle impact during follow-up.

Why it matters

Potential benefit: If successful, this approach could reduce the risk and impact of lymphedema after lymph node surgery in melanoma patients.

How similar studies have gone: Prior lymphedema prevention strategies have shown promise in other settings, but this parallel-cohort pilot explores a novel timing of LVB at surgery in melanoma.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participants greater than or equal to 18 years of age.
2. Participants willing to participate.
3. Participants able to complete informed consent.
4. Participants with a diagnosis of Melanoma undergoing ALND or ILND.

Exclusion Criteria:

1. Participant staking anticoagulants within 7 days prior to surgery.
2. Participants that are known to be pregnant at the time of surgery.
3. Participants with BMI greater than 50.0

Where it's running

  • MD Anderson Cancer Center
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.